TY  - GEN
AU  - Beck,T M
AU  - York,M
AU  - Chang,A
AU  - Navari,R
AU  - Harvey,W H
AU  - Meshad,M
AU  - Griffin,D
AU  - Wentz,A
TI  - Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group
SN  - 0735-7907
PY  - 1997///0825
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antiemetics
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Appetite
KW  - drug effects
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Nausea
KW  - chemically induced
KW  - Neoplasms
KW  - drug therapy
KW  - Ondansetron
KW  - Time Factors
KW  - Vomiting
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3109/07357909709039729
ER  -